Compositions and methods for supporting metabolic and endocrine system function
A composition for supporting metabolism or the endocrine system of a subject includes transfer factor and one or more support components. The transfer factor is useful for preventing, mitigating the effects of, or reversing autoimmunity, as well as for preventing, mitigating the effects or, or reversing oxidative stress. The one or more support components may prevent misregulation of or facilitate regulation of metabolism or endocrine system of the subject. A support or treatment method includes administering transfer factor to a subject, with or without one or more support components.
1. A composition in an oral dosage form, the composition consisting of effective amounts of:
50 mg of a transfer factor-containing component consisting of a source blend of bovine colostrum and chicken egg yolk, the transfer factor-containing component including a non-specific transfer factor;
405 mg of a botanical support component consisting of Pterocarpus marsupium, Gymnema sylvestre , fenugreek, Momordica charantia , and ginseng;
2.8 mg of chromium glycinate nicotinate;
0.75 mg of vanadium; and
30 mg of alpha-lipoic acid.
2. A composition capable of mitigating or reversing effects of autoimmune disorders in a body of a subject, the composition being in an oral dosage form and consisting of effective amounts of:
50 mg of a transfer factor-containing component;
405 mg of a botanical support component consisting of Pterocarpus marsupium, Gymnema sylvestre , fenugreek, Momordica charantia , and ginseng;
2.8 mg of chromium glycinate nicotinate;
0.75 mg of vanadium; and
30 mg of alpha-lipoic acid.
3. The composition of claim 2 , wherein the transfer factor consists of at least one of a mammalian transfer factor source and a nonmammalian transfer factor source.
4. A composition in an oral dosage form and consisting of effective amounts of:
a transfer factor-containing component from at least one of colostrum and egg, the transfer factor-containing component comprising a combination of a non-specific transfer factor and a specific transfer factor;
a botanical support component consisting of Pterocarpus marsupium, Gymnema sylvestre , fenugreek, Momordica charantia , and ginseng; and
an antioxidant consisting of alpha lipoic acid.
5. The composition of claim 4 , wherein the transfer factor-containing component comprises at least one of mammalian transfer factor and nonmammalian transfer factor.
6. The composition of claim 4 , wherein the oral dosage form of the composition includes:
50 mg of the transfer factor-containing component; and
405 mg of a combination of the fenugreek, the Pterocarpus marsupium , the Momordica charantia , the ginseng, and the Gymnema sylvestre.
7. The composition of claim 4 , wherein the oral dosage form of the composition includes:
30 mg of the alpha lipoic acid.
8. A dose of a composition consisting of effective amounts of:
transfer factor sources;
fenugreek;
Pterocarpus marsupium;
Momordica charantia;
chromium;
vanadium;
ginseng;
alpha lipoic acid; and
Gymnema sylvestre,
the dose of the composition decreasing oxidative stress and mitigating effects of autoimmune disorders in a subject.
9. The composition of claim 8 , wherein the transfer factor sources are egg yolk and colostrum.
10. The composition of claim 9 , wherein the colostrum is bovine colostrum.
11. The composition of claim 9 , wherein the egg yolk is chicken egg yolk.
12. The composition of claim 8 , wherein the Momordica charantia is obtained from a fruit of Momordica charantia.
13. The composition of claim 8 , wherein the oral dosage form of the composition includes:
50 mg of the transfer factor-containing component;
405 mg of a combination of the fenugreek, the Pterocarpus marsupium , the Momordica charantia , the ginseng, and the Gymnema sylvestre;
30 mg of the alpha lipoic acid; and
0.75 mg of the vanadium.